- Ambry launches a new genetic test, +RNAinsight that changes the standard for “clinical grade” testing, with higher accuracy.- +RNAinsight enables clinicians – for the first time ever – to conduct both DNA and RNA genetic testing at the same time.- Ambry is the first and only lab to offer paired RNA and DNA genetic testing for hereditary cancer.Ambry Genetics (Ambry), a clinical genetic testing company, announced today the launch of +RNAinsight, a major advancement in genetic testing.
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Deerfield Management Invests $635M to Create Healthcare Innovation Campus for Life Sciences in NYC
- Investment management firm Deerfield Management is investing $635M to create life sciences in New York City.
- Deerfield plans to invest more than $2B in research in seed funding by 2030 to create digital transformation solutions in medicine and treatment.
- It is expected to be in move-in ready condition for Deerfield and other innovators in healthcare by early 2021.
Deerfield Management Company, an investment management firm committed to advancing healthcare through
Read More
Aktana Lands $20M for AI-Enabled Decision Support for Life Sciences
- Aktana raises $20M in debt financing from CIBC Innovation Banking for AI-enabled decision support for the global life sciences industry.
- CIBC Innovation Banking delivers strategic advice, cash management, and funding to innovation companies at each stage of their business cycle, from startup to IPO and beyond.
- Using embedded AI and machine learning refined by real-time human insight, Aktana gives life sciences commercial teams the tools and information to anticipate customer
Read More
Benchling Launches New Products for Research & Biotech Startups to Accelerate Life Sciences Innovation
- Benchling launches two new products that will democratize access to industry-leading data management and collaboration software to the places they happen most: institutions and startup.- With Benchling, organizations from academic institutions, to startups, to major enterprises, can accelerate the pace at which they develop scientific breakthroughs, while minimizing time-consuming, antiquated processes. - The Benchling platform enables scientists to manage the complexity of biology research
Read More
AI-Driven Drug Discovery Startup Unnatural Products Nabs $6M
- Drug discovery startup Unnatural Products, Inc. pairing AI with chemistry to create treatments for drug targets raise $6M in funding led by ARTIS Ventures. - Unnatural Products uses a combination of machine learning and parallel chemistry to change the way we think about treating disease Today ARTIS Ventures has led a $6 million seed round for Unnatural Products, Inc., a Santa Cruz, CA-based drug discovery startup pairing AI with chemistry to create treatments for drug targets that aren’t
Read More
Ensuring A Healthy Approach to Big Data In The Life Sciences Industry
The old adage “knowledge is power” may seem cliched, but it definitely still rings true in the life sciences industry. In fact, maybe more so than in any other industry, healthcare insights are being driven by a vast array of critically important data from scientific research, clinical trials, and patient profiling. Teams are continually asked to identify, prioritize and develop promising therapies which are not only safe but innovative, effective and based on the latest research.
To achieve
Read More
BrightInsight Nabs $25M for Regulated IoT Platform for Biopharma and Medtech
- BrightInsight raises $25M in Series A funding co-led by New Leaf Venture Partners and Eclipse Ventures to further enhance the functionality of its BrightInsight Platform and accelerate global commercialization efforts.
- BrightInsight platform enables regulated drugs, devices and SaMDs to ingest and analyze data and deploy regulated recommendations and insights back to patients and providers
BrightInsight, San Jose, CA-based global regulated digital health platform for biopharma and
Read More
Life Image Launches Real World Imaging for RWE Programs
- Life Image launches Real World Imaging (RWI) offering to respond to researcher needs for maturing insights and accelerating drug development decisions.
- Imaging data, especially for Real World Evidence (RWE), has historically been difficult, if not impossible, to access, retrieve, view, de-identify and normalize at-scale, even though it provides clinically material insights for a growing number of therapies.
- Life Image represents the only company providing large, heterogeneous,
Read More
Tufs Study: Cancer Drugs Now Account for 27% of all New Drug Approvals
Quick Glance- Cancer drugs currently account for 27% of all new drug approvals in the United States since 2010- From 1980 through 2018, the Food and Drug Administration (FDA) approved a total of 126 cancer drugs to treat solid and hematologic tumors- New approaches to development helped to drive the surge in new oncology products, including improvements in clinical trial design, novel drug formats, and a focus on new and validated targetsCancer drugs currently account for 27% of all new drug
Read More
KPMG, Coriell Life Sciences Collaborate on Pharmacogenomics Testing
Coriell Life Sciences will provide pharmacogenomic tests for clients of KPMG’s Care Continuum Optimization, a cloud-based data platform aimed at improving healthcare outcomes and guiding clinicians through transitions in care. Coriell will be running the tests on Thermo Fisher Scientific technology to provide alerts to prescribers when there is the potential for an adverse drug event tied to a patient’s genetics and recommend safer treatment options.KPMG’s Care Continuum Optimization
Read More
